| NCT Number | NCT07325006 |
| Lead Sponsor | Mayo Clinic |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 5,000 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2030-11-30 (estimated) |
| Study Completion | 2030-11-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-07 |